If you are working with individuals with gait deficit due to mild to moderate symptoms of multiple sclerosis (MS), a new treatment and training program is available that can help them get back in step with life.
Are you looking for an alternative option to treat individuals with multiple sclerosis?
Or looking to take physical therapy further for people with MS?
If you are treating gait deficit due to MS, PoNS Therapy™ could augment your therapeutic approach.
Interested in PoNS Training?
Please fill out the form below and our training team will be in touch.
For other inquiries, please speak with a Helius Medical representative by calling 1-877-564-0008 or emailing firstname.lastname@example.org.
What You'll Learn
Our training course will prepare you to become a knowledgeable PoNS trainer. During this free 3-hour course, you will learn about:
How PoNS Works
Learn about the Mechanism of Action (MOA)
How to Use PoNS
Learn how to use the PoNS device for your individuals with MS
Learn how to utilize PoNS software and interpret the data
Meet Your Instructor, Kim Skinner, DPT
I am a physical therapist passionate about helping people improve their health. I began as a clinic PT, working with patients to help them overcome pain and injury. I transitioned to clinical research when I realized that not everyone was able to achieve their functional goals using the tools and techniques that were available through conventional physical therapy. This led me to the University of Wisconsin – Madison, where I worked with a team to develop a program that combined electrotactile stimulation of the cranial nerves via the tongue with physical therapy. We now refer to this as PoNS Therapy™.
It has been both a challenge and a joy to help this therapy translate to use in clinical settings. In the PoNS Therapy training program, you will learn how to successfully implement PoNS Therapy™ with your patients.
Kim Skinner, DPT
Vice President, Training & Clinical Services, Helius Medical
The PoNS device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.